Third, we used the HPA database (immunohistochemistry) to evaluate the expression of CYP2A6, CYP2C9, G6PD, FMO3, and SEC14L2 in normal and HCC tissues. The gene discussed is CYP2C9; the disease is hepatocellular carcinoma.